Published • loading... • Updated
Integrated BioPharma Reports Results for its Quarter and Fiscal Year Ended June 30, 2026
The company said revenue fell 19% from a year earlier as selling and administrative expenses rose, widening the annual loss to $7.6 million.
Summary by The Standard-Journal
3 Articles
3 Articles
The Standard-Journal+2 Reposted by 2 other sources
Integrated BioPharma Reports Results for its Quarter and Fiscal Year Ended June 30, 2026
HILLSIDE, NJ / ACCESS Newswire / September 25, 2026 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the quarter and fiscal year ended June 30, 2026.
·Milton, United States
Read Full ArticleCoverage Details
Total News Sources3
Leaning Left0Leaning Right0Center2Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium
